Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Payables (2020 - 2025)

Historic Payables for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $28.9 million.

  • Celularity's Payables rose 8747.4% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.9 million, marking a year-over-year increase of 8747.4%. This contributed to the annual value of $27.2 million for FY2024, which is 1337.39% down from last year.
  • Celularity's Payables amounted to $28.9 million in Q3 2025, which was up 8747.4% from $28.7 million recorded in Q2 2025.
  • Celularity's Payables' 5-year high stood at $48.5 million during Q3 2022, with a 5-year trough of $5.2 million in Q1 2021.
  • In the last 5 years, Celularity's Payables had a median value of $26.9 million in 2023 and averaged $22.3 million.
  • Its Payables has fluctuated over the past 5 years, first soared by 1169440.73% in 2021, then plummeted by 6729.72% in 2024.
  • Over the past 5 years, Celularity's Payables (Quarter) stood at $9.3 million in 2021, then skyrocketed by 365.95% to $43.4 million in 2022, then decreased by 27.75% to $31.4 million in 2023, then dropped by 13.37% to $27.2 million in 2024, then increased by 6.25% to $28.9 million in 2025.
  • Its last three reported values are $28.9 million in Q3 2025, $28.7 million for Q2 2025, and $27.5 million during Q1 2025.